Home > Insider Trading > Filing (0001062993-25-005289)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1850119	Century Therapeutics Inc.	IPSC	Biological Products, (No Disgnostic Substances) (2836)	842040295

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1867310	Adrienne Farid	C/O Century Therapeutics, Inc. 25 N 38Th Street, 11Th Floor Philadelphia PA 19104	Chief Operations Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-10	2,359	$0.62	131,717	No	4	S	Direct
Common Stock	Acquisiton	2025-03-11	120,000	$0.00	251,717	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2025-03-11	120,000	$0.00	120,000	$0.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
120,000		2035-03-11	No	4	A	Direct

Footnotes

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person.
Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.